サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339319

仮想臨床試験市場、シェア、規模、動向、産業分析レポート：設計別、適応症別、フェーズ別、地域別、セグメント別予測、2023年～2032年

Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
仮想臨床試験市場、シェア、規模、動向、産業分析レポート：設計別、適応症別、フェーズ別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の仮想臨床試験市場規模は2032年までに285億4,408万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

研究開発活動の増加、ヘルスケアのデジタル化、遠隔医療の導入が仮想臨床試験市場を牽引しています。これらの要因によって、臨床試験における仮想試験、遠隔参加、モニタリングのシームレスな統合が可能になります。組織間の連携や政府の支援策も市場の成長に寄与しています。これらの動向は、臨床試験における柔軟性、効率性、患者エンゲージメントの向上を提供する仮想手法への業界の注力を強調しています。

COVID-19の流行は臨床試験に大きな影響を及ぼし、仮想試験の採用拡大につながっています。患者のリクルートと維持に課題が見られ、進行中の臨床試験に混乱が生じた。仮想試験は、パンデミック時に重要な解決策として登場し、参加者が自宅から参加できるようになり、現地訪問が不可能な場合でも研究の継続性を確保できるようになっています。

仮想試験は、遠隔地からのデータ収集、参加者のエンゲージメントの向上、より大規模な集団の組み入れなど、多くの利点を提供します。直接訪問に伴うリスクを最小限に抑え、参加者、コーディネーター、治験責任医師の負担を軽減します。仮想手法を活用することで、臨床試験業界は課題を克服し、効率を高め、迅速かつ効果的なデータ収集を促進することができます。

仮想臨床試験市場レポートハイライト

2022年は、革新的な薬剤のニーズと市場セグメンテーションの流行に伴う試験需要の増加により、介入デザイン分野が市場を独占しました。

がんセグメントは2022年に市場をリードし、がん罹患率の上昇とCOVID-19パンデミック時の患者安全のための仮想トライアルの採用により、その優位性を維持すると予測されます。

北米は、大手製薬企業、政府投資、ヤンセンとPRA Health Sciences社による心不全患者を対象とした分散型カナグリフロジン試験のような共同研究によって、世界の仮想臨床試験市場で大きな収益シェアを占めています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の仮想臨床試験市場に関する洞察

  • 仮想臨床試験市場- フェーズのスナップショット
  • 仮想臨床試験市場力学
    • 促進要因と機会
      • 技術の進歩
      • 研究者がより多様で世界の患者集団にアクセスできるようにする
    • 抑制要因と課題
      • データセキュリティとプライバシーに関する懸念
  • PESTEL分析
  • 仮想臨床試験市場のフェーズの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の仮想臨床試験市場、設計別

  • 主な調査結果
  • イントロダクション
  • 観察試験
  • 介入試験
  • 拡張アクセス試験

第6章 世界の仮想臨床試験市場、適応症別

  • 主な調査結果
  • イントロダクション
  • 中枢神経系
  • 自己免疫/炎症
  • 循環器疾患
  • 代謝・内分泌学
  • 感染症
  • 腫瘍学
  • 泌尿器系
  • 眼科

第7章 世界の仮想臨床試験市場、フェーズ別

  • 主な調査結果
  • イントロダクション
  • フェーズⅠ
  • フェーズⅡ
  • フェーズⅢ
  • フェーズⅣ

第8章 世界の仮想臨床試験市場、地域別

  • 主な調査結果
  • イントロダクション
    • 仮想臨床試験市場評価、地域別、2019～2032年
  • 仮想臨床試験市場-北米
    • 北米：仮想臨床試験市場、設計別、2019～2032年
    • 北米：仮想臨床試験市場、フェーズ別、2019～2032年
    • 北米：仮想臨床試験市場、適応症別、2019～2032年
    • 仮想臨床試験市場-米国
    • 仮想臨床試験市場- カナダ
  • 仮想臨床試験市場- 欧州
    • 欧州：仮想臨床試験市場、設計別、2019～2032年
    • 欧州：仮想臨床試験市場、フェーズ別、2019～2032年
    • 欧州：仮想臨床試験市場、適応症別、2019～2032年
    • 仮想臨床試験市場- 英国
    • 仮想臨床試験市場- フランス
    • 仮想臨床試験市場- ドイツ
    • 仮想臨床試験市場- イタリア
    • 仮想臨床試験市場- スペイン
    • 仮想臨床試験市場- オランダ
    • 仮想臨床試験市場- ロシア
  • 仮想臨床試験市場- アジア太平洋
    • アジア太平洋：仮想臨床試験市場、設計別、2019～2032年
    • アジア太平洋：仮想臨床試験市場、フェーズ別、2019～2032年
    • アジア太平洋：仮想臨床試験市場、適応症別、2019～2032年
    • 仮想臨床試験市場- 中国
    • 仮想臨床試験市場- インド
    • 仮想臨床試験市場- マレーシア
    • 仮想臨床試験市場- 日本
    • 仮想臨床試験市場- インドネシア
    • 仮想臨床試験市場- 韓国
  • 仮想臨床試験市場-中東およびアフリカ
    • 中東およびアフリカ：仮想臨床試験市場、設計別、2019～2032年
    • 中東およびアフリカ：仮想臨床試験市場、フェーズ別、2019～2032年
    • 中東およびアフリカ：仮想臨床試験市場、適応症別、2019～2032年
    • 仮想臨床試験市場- サウジアラビア
    • 仮想臨床試験市場- アラブ首長国連邦
    • 仮想臨床試験市場- イスラエル
    • 仮想臨床試験市場- 南アフリカ
  • 仮想臨床試験市場-ラテンアメリカ
    • ラテンアメリカ：仮想臨床試験市場、設計別、2019～2032年
    • ラテンアメリカ：仮想臨床試験市場、フェーズ別、2019～2032年
    • ラテンアメリカ：仮想臨床試験市場、適応症別、2019～2032年
    • 仮想臨床試験市場- メキシコ
    • 仮想臨床試験市場- ブラジル
    • 仮想臨床試験市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • LEO Innovation Lab
  • Covance Inc
  • CRF Health
  • Oracle Corporation
  • Medable, Inc
  • Paraxel International
  • Clinical Ink, Inc
  • PRA Health Sciences
  • Science 37
  • ICON plc
図表

List of Tables

  • Table 1 Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 2 Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 3 Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 4 Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 6 North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 7 North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 8 U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 9 U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 10 U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 11 Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 12 Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 13 Canada: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 14 Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 15 Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Europe: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 17 UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 18 UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 19 UK: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 20 France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 21 France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 22 France: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 23 Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 24 Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 25 Germany: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 26 Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 27 Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 28 Italy: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 29 Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 30 Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 31 Spain: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 32 Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 33 Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 34 Netherlands: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 35 Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 36 Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 37 Russia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 41 China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 42 China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 43 China: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 44 India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 45 India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 46 India: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 47 Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 48 Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 49 Malaysia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 50 Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 51 Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Japan: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 53 Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 54 Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 55 Indonesia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 56 South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 57 South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 58 South Korea: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 65 UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 66 UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 67 UAE: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 68 Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 69 Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 70 Israel: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 71 South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 72 South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 73 South Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 74 Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 75 Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 76 Latin America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 77 Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 78 Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 79 Mexico: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 80 Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 81 Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 82 Brazil: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 83 Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 84 Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 85 Argentina: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Virtual Clinical Trials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Indication
  • Figure 7. Global Virtual Clinical Trials Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 8. Market by Design
  • Figure 9. Global Virtual Clinical Trials Market, by Design, 2022 & 2032 (USD Million)
  • Figure 10. Market by Phases
  • Figure 11. Global Virtual Clinical Trials Market, by Phases, 2022 & 2032 (USD Million)
  • Figure 12. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Virtual Clinical Trials Market
目次
Product Code: PM1731

The global virtual clinical trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report "Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased research and development activities, healthcare digitization, and the adoption of telehealth drive the virtual clinical trials market. These factors enable seamless integration of virtual trials, remote participation, and monitoring in clinical studies. Collaborations between organizations and supportive government initiatives contribute to the market's growth. These trends emphasize the industry's focus on virtual methods, which offer flexibility, efficiency, and improved patient engagement in clinical trials.

The COVID-19 pandemic has profoundly impacted clinical trials, leading to increased adoption of virtual trials. Challenges in patient recruitment and retention have been observed, and disruptions to ongoing trials have occurred. Virtual trials emerged as a crucial solution during the pandemic, allowing participants to participate from home and ensuring research continuity when site visits were impossible.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Virtual Clinical Trials Market Report Highlights

The interventional design segment dominated the market in 2022, driven by the need for innovative medications and the increased demand for trials amidst the COVID-19 pandemic.

The oncology segment led the market in 2022 and is expected to maintain its dominance due to the rising incidence of cancer and the adoption of virtual trials for patient safety during the COVID-19 pandemic.

North America holds a significant revenue share in the global virtual clinical trials market, driven by major pharmaceutical companies, government investments, and collaborations like Janssen and PRA Health Sciences' decentralized Canagliflozin study for heart failure patients.

The global key market players include: LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37, and ICON plc.

Polaris Market Research has segmented the Virtual Clinical Trials market report based on design, indication, phases, and region:

Virtual Clinical Trials, Design Outlook (Revenue - USD Million, 2019 - 2032)

  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials

Virtual Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology

Virtual Clinical Trials, Phases Outlook (Revenue - USD Million, 2019 - 2032)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Virtual Clinical Trials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Virtual Clinical Trials Market Insights

  • 4.1. Virtual Clinical Trials Market - Phases Snapshot
  • 4.2. Virtual Clinical Trials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Technology
      • 4.2.1.2. Researchers to access a more diverse and global patient population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Security and Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Virtual Clinical Trials Market Phases Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Virtual Clinical Trials Market, by Design

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • 5.3. Observational Trials
    • 5.3.1. Global Virtual Clinical Trials Market, by Observational Trials, by Region, 2019-2032 (USD Million)
  • 5.4. Interventional Trials
    • 5.4.1. Global Virtual Clinical Trials Market, by Interventional Trials, by Region, 2019-2032 (USD Million)
  • 5.5. Expanded Access Trials
    • 5.5.1. Global Virtual Clinical Trials Market, by Expanded Access Trials, by Region, 2019-2032 (USD Million)

6. Global Virtual Clinical Trials Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 6.3. CNS
    • 6.3.1. Global Virtual Clinical Trials Market, by CNS, by Region, 2019-2032 (USD Million)
  • 6.4. Autoimmune/Inflammation
    • 6.4.1. Global Virtual Clinical Trials Market, by Autoimmune/Inflammation, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Global Virtual Clinical Trials Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 6.6. Metabolic/Endocrinology
    • 6.6.1. Global Virtual Clinical Trials Market, by Metabolic/Endocrinology, by Region, 2019-2032 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Global Virtual Clinical Trials Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Oncology
    • 6.8.1. Global Virtual Clinical Trials Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 6.9. Genitourinary
    • 6.9.1. Global Virtual Clinical Trials Market, by Genitourinary, by Region, 2019-2032 (USD Million)
  • 6.10. Ophthalmology
    • 6.10.1. Global Virtual Clinical Trials Market, by Ophthalmology, by Region, 2019-2032 (USD Million)

7. Global Virtual Clinical Trials Market, by Phases

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • 7.3. Phase I
    • 7.3.1. Global Virtual Clinical Trials Market, by Phase I, By Region, 2019-2032 (USD Million)
  • 7.4. Phase II
    • 7.4.1. Global Virtual Clinical Trials Market, by Phase II, By Region, 2019-2032 (USD Million)
  • 7.5. Phase III
    • 7.5.1. Global Virtual Clinical Trials Market, by Phase III, By Region, 2019-2032 (USD Million)
  • 7.6. Phase IV
    • 7.6.1. Global Virtual Clinical Trials Market, by Phase IV, By Region, 2019-2032 (USD Million)

8. Global Virtual Clinical Trials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Virtual Clinical Trials Market - North America
    • 8.3.1. North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.3.2. North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.3.3. North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.4. Virtual Clinical Trials Market - U.S.
      • 8.3.4.1. U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.5. Virtual Clinical Trials Market - Canada
      • 8.3.5.1. Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.4. Virtual Clinical Trials Market - Europe
    • 8.4.1. Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.4.3. Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.4. Virtual Clinical Trials Market - UK
      • 8.4.4.1. UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.5. Virtual Clinical Trials Market - France
      • 8.4.5.1. France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.5.3. France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.6. Virtual Clinical Trials Market - Germany
      • 8.4.6.1. Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.7. Virtual Clinical Trials Market - Italy
      • 8.4.7.1. Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.8. Virtual Clinical Trials Market - Spain
      • 8.4.8.1. Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.9. Virtual Clinical Trials Market - Netherlands
      • 8.4.9.1. Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.10. Virtual Clinical Trials Market - Russia
      • 8.4.10.1. Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.5. Virtual Clinical Trials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.4. Virtual Clinical Trials Market - China
      • 8.5.4.1. China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.4.3. China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.5. Virtual Clinical Trials Market - India
      • 8.5.5.1. India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.5.3. India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.6. Virtual Clinical Trials Market - Malaysia
      • 8.5.6.1. Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.7. Virtual Clinical Trials Market - Japan
      • 8.5.7.1. Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.8. Virtual Clinical Trials Market - Indonesia
      • 8.5.8.1. Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.9. Virtual Clinical Trials Market - South Korea
      • 8.5.9.1. South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.6. Virtual Clinical Trials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.4. Virtual Clinical Trials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.5. Virtual Clinical Trials Market - UAE
      • 8.6.5.1. UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.6. Virtual Clinical Trials Market - Israel
      • 8.6.6.1. Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.7. Virtual Clinical Trials Market - South Africa
      • 8.6.7.1. South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.7. Virtual Clinical Trials Market - Latin America
    • 8.7.1. Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.4. Virtual Clinical Trials Market - Mexico
      • 8.7.4.1. Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.5. Virtual Clinical Trials Market - Brazil
      • 8.7.5.1. Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.6. Virtual Clinical Trials Market - Argentina
      • 8.7.6.1. Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. LEO Innovation Lab
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Covance Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRF Health
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Oracle Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Medable, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Paraxel International
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Clinical Ink, Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PRA Health Sciences
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Science 37
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ICON plc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development